Description, contra-evidence, the application

Latin name: Venlafaxine The pharmacological groups: Acting Substance (MNN) Of venlafaksin * (Venlafaxine *)
According to the data Physicians Desk Reference (2004), venlafaksina hydrochloride in the form of tablets with the immediate liberation is shown for treating the depression. Venlafaxina hydrochloride in the form of capsules with the modified liberation is shown for treating of depression, generalizovannogo alarming disorder and social phobias. Contra-evidence: Hypersensitivity, the simultaneous method of the inhibitors OF MAO (see the "precautionary measures"). Limitations to the application: Recently transferred myocardial infarction and unstable , change AD, the increased intraocular pressure and glaucoma, maniacal states in anamnesis, the initially lowered mass of body, insufficiency, age of up to 18 years (safety and the effectiveness of application they are not established).